Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 10, 2023

Primary Completion Date

July 10, 2027

Study Completion Date

July 10, 2028

Conditions
AIDS
Interventions
DRUG

mesenchymal stem cell

Mesenchymal stem cell dose is 0.75-1.0×10\*6/kg and is transplanted by intravenous infusion. For the mesenchymal stem cell standard treatment group, the cells are used for three times(at week 0, 2,4 after recruitment) and the mesenchymal stem cell enhanced treatment group, the cells are used for six times(at week 0, 2,4,24,26,28 after recruitment).

OTHER

saline

saline is used as placebo in the placebo comparator group

Trial Locations (4)

Unknown

RECRUITING

Beijing 302 Hospital, Beijing

RECRUITING

Beijing YouAn Hospital, Beijing

RECRUITING

Shenzhen Third People's Hospital, Shenzhen

RECRUITING

The Fifth Hospital of Shijiazhuang, Shijiazhuang

All Listed Sponsors
collaborator

Beijing 302 Hospital

OTHER

collaborator

Shenzhen Third People's Hospital

OTHER

collaborator

Fifth Hospital of Shijiazhuang City

OTHER

collaborator

Beijing YouAn Hospital

OTHER

lead

Cell Energy Life Sciences Group Co. LTD

INDUSTRY